MICA and cancer: Published data have demonstrated that the membrane bound form of MICA was prevalently expressed in the low-grade cancers, whereas higher levels of the soluble form (sMICA) were detected in the sera of patients with advanced PDAC, suggesting a correlation with the progression of the disease and the distant metastasis [118].